| ID | Code | Title |
|---|---|---|
| 1759 | PO35 |
Challenges in diagnosis and managment in endobronchial sarcoidosis
; Castaño, Gonzalo; Claus, Murilo; Rolleri, Juan Carlos |
| 2731 | PO61 |
The Home as an Exposure Target in Idiopathic Pulmonary Fibrosis: A Pilot Air Purification Study
; Maggie Urban-Waala; Amanda Morgan; Daniel A Culver |
| 2760 | CO12 |
Effect of nerandomilast in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) by baseline forced vital capacity: subgroup analyses of the FIBRONEER trials
; Ayodeji Adegunsoye; Min Cao; Man Pyo Chung; Yasuhiko Nishioka; Markus Polke; Hui Gu; Kamila Sroka-Saidi; Susanne Stowasser; Marlies S Wijsenbeek; Divya Patel |
| 2763 | CO13 |
Effect of nerandomilast on risk of death in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF)
; Shervin Assassi; Arata Azuma; Vincent Cottin; Anna-Maria Hoffmann-Vold; Michael Kreuter; Toby M. Maher; Luca Richeldi; Claudia Valenzuela; Marlies S. Wijsenbeek; Hui Gu; Gerrit Weimann; Ivana Ritter; Susanne Stowasser; Donald F. Zoz; Fernando J. Martinez |
| 2765 | PO104 |
Efficacy and safety of nerandomilast in the FIBRONEER trials in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF)
; Shervin Assassi; Arata Azuma; Vincent Cottin; Anna-Maria Hoffmann-Vold; Michael Kreuter; Toby M. Maher; Luca Richeldi; Claudia Valenzuela; Marlies S. Wijsenbeek; Daniel Wachtlin; Gerrit Weimann; Ivana Ritter; Donald F. Zoz; Fernando J. Martinez |
| 2943 | PO97 |
Cardiac Sarcoidosis Diagnosed on Explant Pathology Following Heart Transplantation
; Jack Tietema; Jagienka Timek; Mohamad El-Shami; Ryan Hadley; Pranav Kidambi; Renzo Loyaga-Rendon; Ryan Grayburn; Wissam Abdallah; Nagib Chalfoun; Sanjay Dandamudi |
| 2964 | PO15 |
Real-world neurosarcoidosis: clinical phenotypes, management, and outcomes in a single-center cohort
; Giulia Zinni; Alessandro Dell'Edera; Riccardo Scarpa; Marcello Rattazzi; Anna Palmieri; Francesco Cinetto |
| 2965 | PO10 |
Clinical and neurocognitive impact of sarcoidosis: Analysis of Disease Burden and Gender Differences
; Giulia Zinni; Alessandro Dell'Edera; Riccardo Scarpa; Marcello Rattazzi; Anna Palmieri; Francesco Cinetto |
| 2966 | PO74 |
Beyond weight-based dosing: high inter-individual variability and the role of Therapeutic Drug Monitoring (TDM) in the treatment of sarcoidosis with infliximab.
; Giulia Zinni; Alessandro Dell'Edera; Riccardo Scarpa; Anna Palmieri; Marcello Rattazzi; Francesco Cinetto |
| 2971 | PO90 |
Predictive value of FDG uptake in thoracic lymph nodes on PET/CT during immunosuppressive therapy in cardiac sarcoidosis patients
; Harold Mathijssen; Azar Kianzad; Fatima Akdim; Karim Taha; Maarten Jan Cramer; Marcel Veltkamp; Marco C. Post |
| 2978 | PO17 |
Genetic variation across age groups in sarcoidosis
; Sini Koivu; Jimi Virkkala; Katri Ruokamo-Korva; Elisa Lahtela; Inkeri A. Lokki; Marja-Liisa Lokki; Riitta Kaarteenaho; Jaakko Tyrmi; Johannes Kettunen |
| 3060 | PO8 |
Clinical Presentations of Familial Sarcoidosis: A Retrospective Cohort Study from Finland
; Aino Puhakka; Jari Huovinen; Inna Wathén; Joakim Hulkkonen; Terttu Harju; Hannu Vähänikkilä; Hanna Jaula; Johanna Leppänen; Riitta Kaarteenaho |
| 3151 | CO17 |
Integrating Telomere Length Analysis into Pulmonary Fibrosis Diagnosis: Six Years of Experience
; |
| 3169 | PO26 |
Immune checkpoint alterations in B cells and NK cells of obese sarcoidosis patients revealed by EBUS/TBNA lymph node and peripheral blood analysis.
; Iwona Kwiecień; Elżbieta Rutkowska; Rafał Sokołowski; Karina Jahnz-Różyk; Piotr Rzepecki |
| 3170 | PO27 |
PD‑1 and TIM‑3 on NK cells in sarcoidosis: stable across sex and stage, with specific associations to T-cell activation markers.
; Elżbieta Rutkowska; Rafał Sokołowski; Joanna Bednarek; Karina Jahnz-Różyk; Piotr Rzepecki; Agata Raniszewska |
| 3190 | PO120 |
Infection Burden in Sarcoidosis: Insights from a Single-Center Cohort
; Joseph Barney; Drew Robinson |
| 3193 | CO3 |
Diagnostic Delay and Clinical Worsening in Cardiac Sarcoidosis
; H. Mathijssen; J.C. Grutters; M. Veltkamp; F.Akdim; B. de Leeuw; M.C.Post |
| 3199 | PO58 |
Pulmonary Involvement in Systemic Diseases: Clinical Phenotypes, Radiologic Patterns, and Long-Term Functional Outcomes in a Single-Center Cohort
; Marija Šimić; Dina Mihelčić Korte; Tea Vukić Bilić; Mirta Đuzel; Matej Šapina; Marko Banić; Ana Hećimović |
| 3201 | PO85 |
Scar Burden in Cardiac Sarcoidosis Presenting With Malignant Ventricular Arrhythmias
; Selene Rubino; Emma Johns; Andrew Rosenbaum; Courtney Arment; Konstantinos Siontis |
| 3206 | PO2 |
Epidemiology of Sarcoidosis in the United States: Prevalence, Incidence, and Comorbidity Burden
; Haikun Bao; Catherine Allende; Alexandra Z. Sosinsky; Ann Chauffe; Madhu Kanakapura; Prethibha George; Elizabeth Volkmann; Divya Patel |
| 3207 | PO80 |
Risk of Pulmonary Progression and Mortality in US Patients with Sarcoidosis: A 2017–2023 Cohort Study
; Haikun Bao; Catherine Allende; Alexandra Z. Sosinksy; Ann Chauffe; Madhu Kanakapura; Prethibha George; Elizabeth Volkmann; Divya Patel |
| 3212 | CO6 |
Antibiotic Therapy for the Cutibacterium acnes–associated phenotype in sarcoidosis: a randomized controlled trial
; R. Kraaijvanger; C.A. Ambarus; R.G.M. Keijsers; A.F. van den Hoven; J.C. Grutters; M. Veltkamp |
| 3213 | PO33 |
Prevalence of granulomatous inflammation in the lungs in subjects with intrathoracic lymphadenopathy due to sarcoidosis and tuberculosis: Is there a difference?
; Kuruswamy Thurai Prasad; Ritesh Agarwal; Nalini Gupta; Amanjit Bal; Ashutosh Nath Aggarwal |
| 3214 | CO2 |
Financial strain, not income, is associated with worse clinical outcomes in sarcoidosis
; Joyce Lee ScB; Thomas Pulliam MD PhD; Kristen R. Mathias MD MHS; Edward S. Chen MD; Nancy W. Lin MD; Stephen C. Mathai MD MHS; Nisha A. Gilotra MD; Barney Stern MD; Carlos Pardo MD PhD; Kevin Psoter PhD; Michelle Eakin PhD; Michelle Sharp MD MHS |
| 3215 | CO16 |
Impact of underlying genetic cause on clinical characteristics and survival in familial pulmonary fibrosis
; Aernoud A. van Batenburg; Jan C. Grutters; Coline H.M. van Moorsel |
| 3216 | PO34 |
Omega-3 Intake is associated with Improved Clinical Outcomes in Sarcoidosis
; Cierra Poole BS MS; Kristen R. Mathias MD MHS; Edward S. Chen MD; Nancy W. Lin MD; Stephen C. Mathai MD MHS; Nisha A. Gilotra MD; Barney Stern MD; Carlos Pardo MD PhD; Michelle Eakin PhD; Jana Ponce PhD RD LMNT; Michelle Sharp MD MHS |
| 3217 | PO21 |
Building a sarcoidosis biomarker roadmap: finding alignment and building consensus at the Foundation for Sarcoidosis Research’s 2025 Biomarker Summit
; Matthew Baker; Maneesh Bhargava; David Birnie; Ethan Fechter-Leggett; Tim Legenzoff; Joshua Fessel; Mahwash Kassi; Lisa Maier; Mary McGowan; Courtney Montgomery; Mohamed Seedahmed; Chetan Shenoy; Peter H.S. Sporn; Greer Waldrop; Arthur Yee; Tricha Shivas; Elliott Crouser |
| 3218 | PO25 |
Plasma Nuclear Cell-Free Nuclear DNA as a Biomarker in Sarcoidosis: A Multicenter Pilot Study
; Mary Richert; Samantha Shaffer; Hyesik Kong; Temesgen Andargie; Moon J Jang; Ed Chen; Michelle Sharp; Steven Holland; Shambu Aryal; Nabeel Hamzeh; Sean Agbor-Enoh |
| 3219 | PO14 |
Diagnostic and Healthcare Impact of Neurosarcoidosis: Insights from a Decade of Hospital Admission Data
; Michael Lonigro |
| 3222 | CO9 |
Efficacy and Safety of Brepocitinib in Patients with Cutaneous Sarcoidosis: Results from a Randomized, Double-Blind, Multicenter, Placebo-Controlled, Phase II (BEACON) Trial
; Bridget Shields; Margaret Coates; Ogugua Ndili Obi; Anne L. Marano; Aaron Mangold; Oluwakemi Onajin; Anna Haemel; David Fivenson; Daniel A. Culver; Marc A. Judson; Claire Hannah; Craig Smuda; Samantha Polly; Rashmi Unwala; Logan Harper; Manuel Ribeiro Neto; Paras Vakharia; Cuong Nguyen; Galen Foulke; Matthew Helm; Sylvia Hsu; Rohit Gupta; Donna A. Culton; Robert Pariser; Jordan Talia; Katharina S. Shaw; Brendan Johnson; Lauren Graham; Joseph Barney; Sotonye Imadojemu; Avrom S. Caplan; William Damsky |
| 3223 | PO53 |
Infliximab-induced lupus in a patient with probable neurosarcoidosis
; Craig Smuda, MD PhD; Daniel Kurz, MD |
| 3224 | PO108 |
Real-World Use of Tyvaso DPI in Patients with PH-ILD using de-identified US Electronic Health Records
; Kyle Davis; Kellie Morland; Benjamin Wu; Tejaswini Kulkarni |
| 3225 | PO121 |
A randomized controlled trial comparing the diagnostic yield of standard flexible bronchoscopy versus ultrathin bronchoscopy for bronchial mucosal biopsy in sarcoidosis
; Swagatha Jose; Amanjit Bal; Ritesh Agarwal |
| 3228 | PO99 |
VOC Breath Signatures with Diagnostic, Subtype Stratification, and Prognostic potential in Interstitial Lung Diseases
; Eirini Vasarmidi; Ioanna Argyriou; Matthew Kerr; Liam Grimmett; Jessica Herbert; Owen Birch; Tilly Woodland; Huw Davies; Athina Trachalaki; Marilena Lourou; Lutz Wollin; Katerina M. Antoniou |
| 3229 | PO100 |
The role of electronic nose (e-nose) technology in ILD diagnosis and BAL cell discrimination
; Athina Trachalaki; Ioanna Argyriou; Rianne de Vries; Nikoleta Bizymi; Marilena Lourou; Konstantina Symvoulaki; Christian Hesslinger; Daniel Peter; Lutz Wollin; Eliza Tsitoura; Katerina M. Antoniou |
| 3230 | CO5 |
Regulatory T cell-specific CTLA-4 haploinsufficiency enhances T cell activation but does not enhance trehalose dimycolate-induced granuloma formation
; Jelle Miedema; Ingrid Bergen; Jennifer van Hulst; Rudi Hendriks; Odilia Corneth |
| 3231 | PO4 |
Airway exposure to micro- and nanoplastics induces macrophage activation and sarcoidosis-like granulomatous inflammation in mice
; Vicky Bogaard; Ingrid Bergen; Barbro Melgert; Elena Höppener; Ingeborg Kooter; Agnes Boots; Rudi Hendriks; Odilia Corneth; Jelle Miedema |
| 3234 | PO6 |
Sarcoidosis and Malignancy: A Single-Center Cohort Study of Temporal Relationships
; Kathryn Hobbs; Christopher A Thomas; Christopher.King@inova.org; Oksana A Shlobin; Jared D Wilkinson; Junad M Chowdhury; Alan S Nyquist; Anju L Singhal; Zein Kattih; Steven D Nathan; Shambhu Aryal |
| 3236 | PO76 |
Methotrexate polyglutamates concentrations in patients with sarcoidosis treated with methotrexate monotherapy
; Sundaresan J.; Kahlmann V.; Wijsenbeek M.S.; Grutters, J.C.; de Rotte, M; Veltkamp, M |
| 3241 | PO16 |
Looking at the Both Sides of the Coin: A Pooled Analysis of Case Reports with Possible Silicosarcoidosis
; Jasna Tekavec-Trkanjec; Luka Manojlović; Nevenka Piskač Živković |
| 3242 | PO36 |
Bronchial and peritoneal sarcoidosis in a 30 y/o asymptomatic woman: Case report
; Szymon Wojtylak; Grzegorz Romanowicz; Monika Skotarczak; Anna Dubaniewicz |
| 3243 | PO88 |
Artificial intelligence - enhanced EKG predicts presence of cardiac sarcoidosis with a high sensitivity
; Selene Rubino; Jenna Davison; Andrew Rosenbaum; Konstantinos Siontis; Courtney Arment |
| 3245 | PO30 |
Serum KL-6 levels in sarcoidosis and hypersensitivity pneumonitis: a prospective comparative study
; Shivani Pundeer; Mandeep Sadhra; Amanjit Bal |
| 3246 | PO62 |
Post-COVID ILD or Fibrotic HP? A Diagnostic Dilemma
; Aykut Çilli |
| 3250 | PO98 |
ASYMPTOMATIC HEART AND OCULAR INVOLVEMENT IN MULTIORGAN SARCOIDOSIS IN 34-YEAR-OLD PATIENT
; Żegleń Sławomir; Oskar Okuniewski; Jankowska Hanna; Panasik Agnieszka; Skotarczak Monika |
| 3251 | PO37 |
Happy Ending Story: A Case of Sarcoidosis
; Zeynep Yaren Yilmaz Tan; Umran Erbay; Sertas Erarslan; Mehmet Korkmaz |
| 3253 | PO38 |
Tuberculosis, malignancy or Sarcoidosis? A diagnostic puzzle in an HIV Patient
; Jorge Soares; Miguel Lopes |
| 3254 | PO9 |
Characteristics of comorbid sarcoidosis and inflammatory bowel disease in a sample of US Black women
; Adjoa Anyane-Yeboa; Cordelia W. Russell; Hamed Khalili; Yvette C. Cozier |
| 3255 | PO109 |
Pulmonary Hypertension in Systemic Sclerosis: Group 1 or Group 3? A Therapeutic Challenge
; Gokhan Altan; Zuleyha Bıngol; Derya Baykız; Murat İnanc |
| 3256 | PO31 |
Sarcoidosis phenotypes identified by [18]FDG PET/CT. A proof of concept study.
; Anna Goljan-Geremek, PhD MD; Agnieszka Kołodzińska,PhD MD dr hab. n. med.,; Renata Główczyńska PhD MD; Elżbieta Puścińska PhD,MD; Konrad Giełdowski MD; Michał Kocemba MD; Krzysztof Bieńkowski MD; Joanna Żuchowska MD; Sonia Borodzicz-Jażdzyk PhD,MD; Katarzyna Romanowska-Próchnicka PhD,MD; Patrycja Nejman-Gryz,PhD,MD; Marta Maskey-Warzęchowska, PhD,MD; Lena Kalinowska; Rafał Krenke PhD,MD |
| 3258 | PO117 |
A Single Disease, Multiple Patterns: The Spectrum of Pulmonary Function Tests in Sarcoidosis
; Gökhan Altan; Sama Hasanova; Esen Kıyan; Gülfer Okumuş |
| 3259 | PO11 |
Decreasing quality of life associated with increased organ involvement in sarcoidosis: learnings from the Foundation for Sarcoidosis Research (FSR) Patient Registry
; Elliott Crouser; Logan Harper; Mary McGowan; Leslie Serchuck; Tricha Shivas; Elise Hoover |
| 3261 | PO39 |
Sarcoidosis Mimicking Malignancy: A Diagnostic Challenge
; Carla Margarida Carvalho; Raquel Pereira; Eva Dias Padrão |
| 3262 | PO40 |
Sarcoid-like reaction in mediastinal lymph nodes to lung cancer in a 67-year old woman
; Żegleń Sławomir; Oskar Okuniewski; Skotarczak Monika; Szymon Wojtylak; Grzegorz Romanowicz |
| 3263 | PO69 |
The prednisone-free regimens exploratory (PREDFREE) study - A real-world analysis of corticosteroid-tapering sarcoidosis treatment regimens with complete corticosteroid withdrawal
; Ogugua Ndili Obi; Manuel Ribeiro Neto; Nadera Sweiss; Kerry Hena; Dan Culver; Recai Yucel; Paul Feustel; Sai Anoosh Parimi; Derlis Fleitas Sosa; Sanya Chandna; Supritha Prasad; Nathaniel Nelson; Shravya Dharambhat; Joseph Mazur; Sooyeon Kwon; Marc Judson |
| 3267 | PO78 |
Perceived Medication Toxicity and Health-Related Quality of Life in Pulmonary Sarcoidosis
; Cierra Poole BS, MS; Chatuthanai Savigamin, MD; Nancy W. Lin, MD; Edward S. Chen, MD; Michelle Sharp, MD, MHS |
| 3268 | PO113 |
SupportSarc: Protocol for A Randomized Controlled Trial of Virtual Mindfulness-Based Stress Reduction for Sarcoidosis-Associated Fatigue
; Angie Corrigan; Amanda J Shallcross ND, MPH; Xiaofeng Wang PhD; Donita Al-Amin; Dena Aruta BS, MT (ASCP); Kathleen Pantea LPN; Johnie Reed DBA; Marc Judson MD; Daniel A Culver DO |
| 3269 | CO4 |
Bronchoalveolar Lavage Protein Panel to Detect Beryllium Sensitization and Chronic Beryllium Disease
; Brian Vestal; Danielle O Weise; Timothy J Griffin; Pratik D Jagtap; Joshua Macaluso; L Ealine Epperson; Margaret Mroz; Lisa A Maier; Li Li |
| 3270 | PO12 |
Stress and Self-Efficacy as Key Drivers of Symptoms in Sarcoidosis — A Cross-Sectional Survey Study
; Maeve MacMurdo MBChB, MPH; Elise Hoover MPH; Xiaofeng Wang PhD; Manuel Lessa Ribeiro Neto MD; J. Daryl Thornton MD, MPH; Daniel A Culver DO |
| 3272 | PO28 |
Characterizing the Phosphorylation Landscape to Understanding Altered Kinase Signaling in Pulmonary Sarcoidosis
; Danielle O Weise; Li Li; Timothy J Griffin; Pratik D Jagtap; Subina Mehta; Justin M Drake; Megan L Ludwig; Briana Q Barkes; Eric F Lock; Lisa A Maier; Maneesh Bhargava |
| 3273 | PO75 |
Long-term infliximab therapy in refractory pulmonary and extra-pulmonary sarcoidosis provides sustained clinical benefit
; Joseph Barney MD; Ishan Lalani MD |
| 3276 | PO55 |
Diagnostic Journey and Care Pathways in Progressive Fibrosing ILDs in Portugal: interim results from a national registry
; Alexandra Borba; Ana Loureiro; Ana Verónica Cardoso; Carla António; Catarina Pereira; David Barros Coelho; Daniela Neves; Lígia Fernandes; Marisa Anciães; Miguel Lopes; Nelson Marçal; Pedro Gonçalo Ferreira; Rita Pinto Basto; Rita Simões; Susana Clemente; Sofia Neves; António Morais; Vanda Areias |
| 3278 | PO94 |
Steroid stewardship in cardiac sarcoidosis: bone health monitoring and prevention in a tertiary cardiac sarcoid cohort
; Juan Carlos Quijano-Campos; Fiona Kearl; Marina Zaromytidou; Gavin Thomas; Neha Sekhri; Richard Toshner |
| 3281 | PO93 |
Angiotensin receptor-neprilysin inhibitor (Sacubitril/Valsartan) in cardiac sarcoidosis induced heart failure; real-world experience from a nurse-led clinic
; Dr Rakesh Sharma; Dr Vasileios Kouranos |
| 3282 | PO101 |
Myoferlin — new player in idiopathic pulmonary fibrosis pathogenesis?
; Mervi Kreus; Steffen Ohlmeier; Siri Lehtonen; Henna karvonen; Elisa Lappi-Blanco; Johanna Leppänen; Riitta Kaarteenaho |
| 3284 | PO41 |
Not All Granulomas Are Sarcoidosis: Vertebral Tuberculosis Mimicking Disease Progression
; Mariana Godinho; Gabriela Santos; Carlos Araújo; Inês Estalagem; Inês Oliveira; Miguel Lopes |
| 3286 | PO119 |
Clinical bronchial hypersensitivity in sarcoidosis - more significant than we think?
; Patrycja Nejman-Gryz; Anna Goljan-Geremek; Elżbieta Puścińska; Małgorzata Kobylecka; Joanna Żuchowska; Patrycja Roguska; Magdalena Dąbrowska; Maria Kaczorowska-Małek; Marta Maskey-Warzęchowska; Rafał Krenke |
| 3290 | PO63 |
Not All Cysts Are the Same: A Single-Center Experience in Cystic Lung Diseases
; Gökhan Altan; Ayşe Nur Ertuğrul; Esen Kıyan; Züleyha Bingöl |
| 3291 | PO1 |
Sex-based phenotypic differences and outcomes in sarcoidosis: data from the SARCO-I Spanish multicentre registry
; Joel Francesqui; Daniel Ramos; Elena Bollo de Miguel; Ana Villar Gomez; Pablo Flórez Solarana; Eva Balcells Vilarnau; Gema Castaño; Erwin Pinillos Robles; Raul Godoy Mayoral; Belén López Muñiz; María José Soler-Sampere; Diego Castillo; Albert Rafecas-Codern; Pablo Mariscal Aguilar; Luis Gomez Carrera; Gema Bonilla; Paloma Millan Pilli; Karina Portillo; Fernanda Hernández-González; Jacobo Sellares |
| 3292 | PO32 |
Changes in T cell cytokine profiles at baseline associate with treatment response in the PREDMETH study
; Willemijn L. Driesse; Marlies S. Wijsenbeek; Vivienne Kahlmann; Catharina C. Moor; Montse Janssen Bonás; Marcel Veltkamp; Rudi W. Hendriks; Jelle R. Miedema; Odilia B.J. Corneth |
| 3293 | PO23 |
Clinical Application of Serum Lymphopenia in Sarcoidosis Evaluation: Can It Serve as a Marker of Disease Extent and Disability?
; Patrycja Nejman Gryz; Malgorzata Kobylecka; Elzbieta Puscinska; Agnieszka Kolodzinska; Renata Glowczynska; Sonia Borodzicz Jazdzyk; Joanna Zuchowska; Katarzyna Romanowska Prochnicka; Marta Maskey Warzechowska; Julia Rutkowska; Lena Kalinowska; Jolanta Kunikowska; Rafal Krenke |
| 3294 | CO11 |
Decline in Forced Vital Capacity and Survival in fibrotic Hypersensitivity Pneumonitis; Time to revisit the definition of Progressive Pulmonary Fibrosis guidelines?
; J. Tadjkarimi; A. Trachalaki; E. Renzoni; S. Bax; R. Hewitt; G. Jenkin; P. George; C. Stock; A. Wells |
| 3295 | PO106 |
Nintedanib Affects Adaptive Immunity in Idiopathic Pulmonary Fibrosis
; Stefan Neys; Willemijn Driesse; Jennifer Schipper-van Hulst; Rudi Hendriks; Thomas Koudstaal; Odilia Corneth |
| 3297 | PO81 |
FVC Decline in Advanced Pulmonary Sarcoidosis is Associated with Reduced Survival: Results of the ReAS Study
; Ogugua N. Obi; Robert P. Baughman; Marc Judson; Surinder Birring; Helmi Van Hirtum; Marcel Veltkamp; W. Ennis James; Lisa Maier; Violetta Vucinic; Eva Carmona; Mehdi Mirsaedi; Vasileios Kouranos; Athol U. Wells; Elyse E. Lower |
| 3301 | CO14 |
Pulmonary Hypertension Screening in Interstitial Lung Disease: Interim Comparison of Clinician Suspicion vs Right Heart Catheterization in the PHINDER Study
; Sandeep Sahay; Tejaswini Kulkarni; Oksana Shlobin; Abhijit Raval; David Kiely; Maral DerSarkissian; Matthew Hunsucker; David Zisman; Meredith Broderick; Dasom Lee; Kevin Maher; Mary Beth Scholand |
| 3304 | PO43 |
Granulomatous Lung Disease Mimicking Sarcoidosis in a Patient with Silica Exposure
; Ana Verónica Cardoso |
| 3307 | PO107 |
Interstitial Lung Disease with and without Mean Pulmonary Artery Pressure >20 mmHg: Interim Results from the PHINDER Study
; Bradford Bemiss; Oksana Shlobin; David Zisman; Karla Cruz Morel; Maral DerSarkissian; Tejaswini Kulkarni; Meredith Broderick; Dasom Lee; Kevin Maher; Mary Beth Scholand; David Kiely |
| 3308 | PO73 |
Targeting the JAK-STAT pathway in Progressive Fibrotic Pulmonary Sarcoidosis: Functional and Physiologic Improvement with Tofacitinib in a 20-Patient Case Series
; Atefeh Abedini; Pegah Soltani; Akram Ghanavati; Kimia Taghavi |
| 3309 | CO8 |
One-year follow up of the PREDMETH trial; a randomized controlled trial comparing prednisone with methotrexate in pulmonary sarcoidosis
; Marlies Wijsenbeek; Montse Janssen Bonás; Jan C. Grutters; Rémy L.M. Mostard; Henricus N.A.J. van Rijswijk; Jan van der Maten; Kelly M.C. van Doorn; Linda A.A. Moonen; Maria J. Overbeek; Bart Koopman; Marco Grootenboers; Esther J. Nossent; Michiel Wagenaar; Henk Kramer; Eveline Schakenraad; Peter I. Bonta; Stefan Walen; Chantal Knoops; Mayka Overgaauw; Marcel Veltkamp; Catharina C. Moor; Vivienne Kahlmann |
| 3310 | PO105 |
Determinants of Long-Term Progression in Hypersensitivity Pneumonitis: The Role of Phenotype and Early Lung Function Change
; Marko Banić; Dina Mihelčić Korte; Dina Rnjak; Ana Hećimović |
| 3311 | PO5 |
Occupational and Environmental Associations with Baseline Organ Involvement in a Real-World Sarcoidosis Cohort
; Josh J. Solomon, MD; Briana Q. Barkes; Margaret M. Mroz; Mary E. Richert; Clara I. Restrepo; Lisa A. Maier |
| 3313 | CO7 |
Impact of Early Diagnosis and Early Initiation of Infliximab on Long-Term Disability in Neurosarcoidosis
; Scott Husak; Manuel L. Ribeiro Neto, MD; Daniel A. Culver, DO; Julia O'Mahony, PhD |
| 3315 | PO13 |
Ten Clinical Sites Across the United States to Collaborate to Collect Data on Patients with Multisystem Sarcoidosis
; Mridu Gulati; Matthew Baker; Briana Barkes; Paula Barreras; William Damsky; Ethan Fechter-Leggett; Elizabeth Frame; Logan Harper; Taylor Harwood; Ravi Karra; Timothy Legenzoff; Craig Lipset; Mary McGowan; Courtney Montgomery; Brandon Moss; Ogugua Obi; Misha Rosenbach; Farooq H. Sheikh; Peter H.S. Sporn; Leslie Serchuck; Tricha Shivas; Lisa Maier |
| 3316 | PO116 |
Association of respiratory oscillometry with health-related quality of life in sarcoidosis
; Cierra Poole; Kevin Psoter; Kristen Mathias; Edward Chen; Nancy Lin; Stephen Mathai; Michelle Eakin; Michelle Sharp |
| 3321 | PO115 |
Delphi CT Phenotypes of Sarcoidosis: Reliability, and Lung Function Associations
; Wren L Lippitt, PhD; Giovanni Mancò, MD; Samuel Friedlander, MD; Shu-Yi Liao, MD, MPD, ScD; Briana Q Barkes, MPH; Margaret M Mroz, MS; Tasha E Fingerlin, PhD; Nichole E Carlson, PhD; David A Lynch, MB, BCh |
| 3325 | PO20 |
Epigenetic and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells in Fibrotic and Non-Fibrotic Pulmonary Sarcoidosis
; Brian Vestal, PhD; Camille Moore, PhD; Cheyret Wood MS; Jonathan Cardwell, MS; Joshua Macaluso; Margaret M. Mroz, MS; Clara I. Restrepo, MD; Ivana Yang, PhD; Li Li, MD, PhD |
| 3326 | PO51 |
Fibrotic pulmonary sarcoidosis with persistent inflammatory activity: corticosteroid toxicity and barriers to treatment escalation
; Ana Castelo Grande; Nuno de Barros Ferreira; Ivone Gonçalves |
| 3327 | PO59 |
Impact of Rheumatologist Involvement on Diagnostic and Treatment Optimization in Interstitial Lung Disease
; Teresa Machado; Luís Lázaro; Eduarda Tinoco; Cristina Alves; Carla Nogueira; Patrícia Pinto; Ana Ribeiro; Célia Sousa; Inês Marques; Sérgio Campainha; Sofia Neves |
| 3328 | CO10 |
Integrating DLCO with FVC in Fibrotic Hypersensitivity Pneumonitis: How do we better model mortality in Progressive Pulmonary Fibrosis ?
; Evelyn Lynn; Punchalee Kaenmuang; Athina Trachalaki; Vasileios Kouranos; Peter George; Simon Bax; Maria Kokosi; Carmel Stock; Richard Hewitt; Elizabeth Renzoni; Athol Wells |
| 3339 | PO111 |
Prevalence and Characteristics of Sarcoidosis-associated Myositis, A Single Center Cohort Experience
; Joseph Barney |
| 3340 | PO45 |
Immunotherapy-induced sarcoidosis: A case series
; Francisco Mano; Inês Coutinho; Pedro Ferreira; Tiago Alfaro; Margarida Afonso |
| 3344 | PO46 |
Post-COVID-19 Sarcoidosis: An Emerging Clinical Phenotype and Diagnostic Challenge
; Matilde Ferreira de Almeida; João Cruz; Miguel Silva Lopes; Jorge Humberto Soares |
| 3351 | PO19 |
Peripheral blood leukocyte telomere length, fatigue, and pulmonary fibrosis in sarcoidosis: a cross-sectional study.
; Daria Domańska-Senderowska; Monika Migdalska-Sęk; Anna Litwin; Łukasz Izbiński; Ewa Brzeziańska-Lasota; Wojciech Jerzy Piotrowski |
| 3352 | PO67 |
A Spectrum of Lymphoproliferation: From LIP to MALT Lymphoma in Sjögren Syndrome
; Sofia Martins Castro; Maria Aurora Mendes; Eduardo Dourado; Dino Andrade Luís; Margarida Ferreira; João Cravo |
| 3353 | PO72 |
Evaluation of the impact of methotrexate on patients with chronic sarcoidosis
; Robert P. Baughman; Sergey N. Avdeev; Irina Yu. Vizel; Gulnaz R. Shakirova |
| 3357 | PO29 |
IDO1 as an Immunometabolic Checkpoint of Granuloma Formation in Sarcoidosis
; Diana Santos-Ribeiro; Relber A. Gonçales; Cátia Rodrigues; Francisca Costa; Oksana Sokhatska; Chiara Suvieri; Luís Delgado; António Morais; Natalia V Rivera; Claudia Volpi; Hélder Novais Bastos; Cristina Cunha; Agostinho Carvalho |
| 3358 | CO1 |
Clinical and phenotypic characterisation of pulmonary sarcoidosis in Spain: a multicentre cluster analysis
; Elena Bollo; Ana Villar; Pablo Flórez; Eva Balcells; Gema Castaño; Erwin Javier Pinillos-Robles; Raúl Godoy-Mayoral; Belén López-Muñíz; María José Soler-Sampere; Diego Castillo; Albert Rafecas-Codern; Pablo Mariscal-Aguilar; Paloma Millan-Billi; Karina Portillo; Fernanda Hernandez-Gonzalez; Jacobo Sellares |
| 3361 | PO89 |
Enhanced Myocardial Suppression on ¹⁸F-FDG PET/CT in Suspected Cardiac Sarcoidosis with an 18-Hour Fasting Protocol
; D Vriens; FAJ Esser; HMJ Siebelink; JL Stöger; JJ Goeman; JRG Torremans; MM Tjong Joe Wai; P Dibbets-Schneider; MJJ Geelhoed; FL Stevens; MK Ninaber; LF de Geus-Oei |
| 3364 | PO54 |
Progressive Fibrosing ILD in Portugal: Interim Epidemiological and Clinical Results from a National Multicenter Registry
; Alexandra Borba; Ana Loureiro; Ana Verónica Cardoso; Carla António; Cláudia Guerreiro ; Catarina Pereira; David Barros Coelho; Daniela Neves; Lígia Fernandes; Marisa Anciães; Miguel Lopes; Nelson Marçal; Pedro Gonçalo Ferreira; Rita Pinto Basto; Rita Simões; Susana Clemente; António Morais |
| 3366 | PO52 |
Anti-Tumor Necrosis Factor Therapy Induced Neurosarcoid: A Curiosity or a Cautionary Tale?
; |
| 3370 | PO79 |
Clinical Profile and Prognostic Determinants of Pulmonary Sarcoidosis: A Real-World Experience from a Regional Referral Center
; Filipa Lemos e Aguiar; Francisco Cadarso; Ivone Gonçalves; Ana Verónica Cardoso |
| 3371 | CO15 |
Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis: Insights from 71 Patients
; Amira Benattia; Carmel Stock; Manuel Lopez Meseguer; Effrosyni Manali; Berta Saez-Gimenez; Cormac McCarthy; Donal O'Malley; Frantzeska Frantzeskaki; Ioannis Tsagkaris; Elzbieta Radzikowska; Claudia Ravaglia; Roberto Cassandro; Davide Elia; Spyridon Papiris; Venerino Poletti; Sergio Harari; Laura Price; Abdellatif Tazi; Athol Wells; Maria Kokosi |
| 3372 | CO18 |
Clinical Significance of Serum KL-6 in Fibrotic Interstitial Lung Diseases
; Eirini Vasarmidi; Athina Trachalaki; Carmel Stock; Vasileios Kouranos; Felix Chua; Simon Bax; Richard Hewitt; Elisabetta Renzoni; Nikolaos Tzanakis; Peter George; Athol Wells; Katerina Antoniou |
| 3373 | PO84 |
Sex Disparities in ECG Screening at Initial Sarcoidosis Diagnosis: A Retrospective Study of 7,468 Adults
; Logan J Harper MD, MS; Daniel A Culver DO; Manuel L. Ribeiro Neto MD, PhD |
| 3374 | PO56 |
Characterization of a Multicenter Portuguese Cohort with Unclassifiable Interstitial Lung Disease
; Ana Rita Ribeiro; Andreia Daniel; Carla Carvalho; Pedro Vicente de Almeida; Helena Carvalho; Nuno Ferreira; Luís Silva; André Alexandre; David Coelho; Hélder Novais Bastos; Patrícia Mota; Natália Melo; Susana Guimarães; Conceição Souto Moura; André Carvalho; António Morais |
| 3375 | PO57 |
The role of biopsy in the diagnosis and management of Unclassifiable Interstitial Lung Disease
; Rita de Vasconcelos Pereira; Andreia Daniel; Carla Carvalho; Pedro Vicente de Almeida; Helena Carvalho; Nuno Ferreira; Luís Silva; André Alexandre; David Coelho; Hélder Novais Bastos; Patrícia Mota; Natália Melo; Susana Guimarães; Conceição Souto Moura; André Carvalho; António Morais |
| 3376 | PO102 |
The Vagus Nerve conducts viable translocation of gut flora to the lungs that impacts interstitial lung disease severity in mice
; Amit Kuman; Pooja Keerthipati; NOrberto Gonzalez-Juarbe |
| 3377 | PO95 |
Hemodynamic and Histopathologic Features of Pulmonary Hypertension in Explants from Advanced Pulmonary Sarcoidosis
; Colin Dunn; Amandeep Aneja; Rohit Gupta |
| 3378 | PO65 |
Alveolar macrophage pneumonia: impact of smoking cessation and corticosteroid therapy
; Ana Rita Ribeiro; Pedro Vicente de Almeida; Carla Carvalho; Helena Carvalho; Luís Silva; Nuno Ferreira; Rita de Vasconcelos Pereira; André Alexandre; David Coelho; Hélder Novais Bastos; Patrícia Mota; Natália Melo; Susana Guimarães; Conceição Souto Moura; André Carvalho; António Morais |
| 3379 | PO103 |
Telomere-Related Gene Variants in Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
; Rita F. Santos; Nuno Osório; Diana Gomes; Andreia Coelho; Mariana Resende; David Coelho; Janete Santos; Oksana Sokhatska; Marília Beltrão; Natália Melo; Patrícia Mota; André Terras; André Carvalho; Susana Guimarães; Conceição Souto Moura; Ana Grangeia; António Morais; Hélder Novais Bastos |
| 3380 | PO114 |
Fatigue Assessment in Patients with Sarcoidosis Using the Fatigue Assessment Scale
; Cláudia Sousa; Pedro Mendes; Rudi Fernandes; Samuel Pereira; Vítor Teixeira |
| 3381 | PO22 |
Inflammatory Markers and Disease Severity in Sarcoidosis
; Cláudia Sousa; Pedro Mendes; Rudi Fernandes; Samuel Pereira; Vítor Teixeira |
| 3382 | PO47 |
Lung Adenocarcinoma Mimicking Sarcoidosis: A Case Report and Diagnostic Challenge
; Cláudia Sousa; Pedro Mendes; Rudi Fernandes; Samuel Pereira; Vítor Teixeira |
| 3383 | PO60 |
Characterization of household mould exposure in patients with fibrotic ILDs
; Mariana Resende; Diana Gomes; Inês Luís; João Rufo; Mónica Vieira; David Coelho; Rita F. Santos; Janete Santos; Oksana Sokhatska; Marília Beltrão; Natália Melo; Patrícia Mota; André Terras; André Carvalho; Susana Guimarães; Conceição Souto Moura; António Morais; Hélder Novais Bastos |
| 3384 | PO48 |
Asymptomatic Primary Cavitary Sarcoidosis: A Case of Radiological Progression Guiding Treatment Decision
; Teresa Machado; Luís Lázaro; Carina SIlva; Inês Marques; Eduarda Tinoco; Cristina Alves; Carla Nogueira; Sérgio Campainha; Sofia Neves |
| 3385 | PO96 |
Aortic Involvement in Sarcoidosis: An Underrecognized Manifestation Revealed by 18F-FDG PET-CT
; Gonçalo Moura Portugal; Joana Rodrigues Barbosa; Sara Salgado; Rita Pinto Basto |
| 3386 | PO49 |
Beyond the Chest CT: Sight-Threatening Neuro-Ophthalmic Sarcoidosis Emerging From an Apparent Lofgren Syndrome
; Dhairya Shah; Fatima Abdulle |
| 3388 | PO50 |
“From Chest to Brain”: Three Clinical Presentations of Neurosarcoidosis Spectrum
; Mariana Rodrigues de Oliveira; Leandra Fagundes; Juliana Barata; Eunice Magalhães; Pedro Ferreira; Maria La Salete Valente |
| 3431 | PO118 |
Effect of Race-Neutral (GLI Global 2022) versus Race-Based (GLI 2012) Spirometry Reference Equations on Pulmonary Function Test Interpretation in Sarcoidosis
; Lusmelys Guevara; Noah Andersen; Jica Garces; Kenny Alvarado; Mohammad Ahmadzai; Reema Ismail |
| 3432 | PO3 |
Race-stratified phenotype of sarcoidosis in community pulmonary practice: a 10-year, multisite experience
; Lusmelys Guevara; Noah Andersen; Jica Garces; Kenny Alvarado; Mohammad Ahmadzai; Reema Ismail |
| 3433 | PO71 |
Race and pharmacologic treatment patterns in patients with sarcoidosis: A 10-year, multisite community pulmonary practice experience
; Jica Garces; Noah Andersen; Lusmelys Guevara; Kenny Alvarado; Mohammad Ahmadzai; Reema Ismail |
| 3476 | PO70 |
Steroid-Sparing and Pulmonary Stability Across XTMAB-16 Dose Regimens in Pulmonary Sarcoidosis: Cohort-Level Findings from XTMAB-16-201 Part A
; Thomas Matthews; Keith Robinson |
| 3500 | PO64 |
The Diagnostic Journey in Rare Interstitial Lung Diseases in Türkiye: A Multicenter TRILD Registry Study on Healthcare Levels, Referral Pathways, and Timing
; Nazli Cetin; Orkun Eray Terzi; Goksel Altinisik; Ozlem Ozdemir Kumbasar; Ilknur Basyigit; Sureyya Cetin Yilmaz; Burcu Baran; Asli Alkan; Kubra Gungor; Zuleyha Bingol; Gulfer Okumus; Gokhan Altan; Serhat Erol; Habibe Hezer; Serap Argun Baris; Oguz Karcioglu; Inci Gulmez; Pinar Yildiz Gulhan; Damla Serce Unat; Celalettin Korkmaz; Omer Ozbudak; Nurdan Kokturk; Talat Kilinc; Gulsah Gunluoglu; Aliye Gamze Calis; Hulya Dirol; Mehmet Parlak; Kubra Taskaraca Karabacak; Ilker Yilmam; Senay Yilmaz; Elif Yelda Niksarlioglu; Elif Yildirim; Nesrin Ocal; Oguz Uzun; Fatma Arslan; Aylin Ozgen Alpaydin; Ramazan Eren; Emine Aksoy; Ezgi Demirdogen; Sermin Borekci; Nazli Huma Teke; Derya Kocakaya; Gulru Polat; Aycan Yuksel; Ceren Ilgar Akelma; Ilgim Vardaloglu; Aysu Sinem Koc; TRILD Study Group; Eylem Sercan Ozgur |
| 3503 | PO66 |
Determinants of Disease Progression in Immunosuppressive Therapy–Treated Rare Cystic and Interstitial Lung Diseases: A Multicenter Real-World Study from the TRILD Registry
; Goksel Altinisik Ergur; Ozlem Ozdemir Kumbasar; Burcu Baran; Aslı Alkan; Gulsah Gunluoglu; Serap Argun Baris; Oguz Uzun; Gulfer Okumus; Zuleyha Bingol; Elif Yelda Ozgun Niksarlioglu; Hulya Dirol; Inci Gulmez; Habibe Hezer; Aylin Ozgen Alpaydin; Mehmet Parlak; Aycan Yuksel; Sureyya Cetin Yilmaz; Oguz Karcioglu; Senay Yilmaz; Pinar Yildiz Gulhan; Ilknur Basyigit; Ismail Hanta; Gokhan Altan; Ozge Oral Tapan; Omer Ozbudak; Kubra Gungor; Nurdan Kokturk; Ahmet Ursavas; Derya Kocakaya; Nurevsan Kusdogan; Talat Kilic; Fatma Arslan; Nesrin Ocal; Ilker Yılmam; Ersin Alkilinc; Meltem Agca; Ilgim Vardaloglu; Emine Arguder; Isil Uzel; Baris Demirkol; Nazli Cetin; Orkun Eray Terzi; Ceren Ilgar Akelma; Ceren Degirmenci; Aysu Sinem Koc; Serhat Erol; Eylem Sercan Ozgur; Gulru Polat |
| 3612 | PO122 |
Itaconate Restrains Granuloma Formation by Modulating Macrophage Activation and Transformation
; Relber A. Gonçales; Marcela Oliveira; Diana Santos-Ribeiro; Rita Silva-Gomes; António Morais; Hélder Novais e Bastos; Cristina Cunha; Agostinho Carvalho |
| 3613 | PO123 |
Evaluating efzofitimod in a subset of sarcoidosis with the restrictive phenotype
; Pavithra Ramesh, MS; Sanjay Shukla, MD; Nelson Kinnersley PhD; Daniel A. Culver, DO |